IO Biotech, Inc.

IOBTQ Healthcare Biotechnology

In the quarter to September 2025, EPS grew 63.9% and free cash flow grew 11.2%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$3.5M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Dec '24 Mar '25 Jun '25 Sep '25
Current Ratio

+8 more quarters

3.33 2.32 1.96 2.01
Net Debt/EBITDA
2.23 1.65 0.93 0.73
Debt/Equity
0.00 0.00 4.22 18.29
Free Cash Flow per Share
(0.30) (0.35) (0.30) (0.28)
Book value per Share
0.71 0.40 0.02 0.01
Free Cash Flow
(19.64) (23.10) (19.85) (18.48)
Other line items

Show all line items

Columns are period end dates